BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND TNFRSF17, BCMA, 608, ENSG00000048462, CD269, Q02223, BCM AND Treatment
32 results:

  • 1. Immunotherapy targeting B cells and long-lived plasma cells effectively eliminates pre-existing donor-specific allo-antibodies.
    Zhang Z; Markmann C; Yu M; Agarwal D; Rostami S; Wang W; Liu C; Zhao H; Ochoa T; Parvathaneni K; Xu X; Li E; Gonzalez V; Khadka R; Hoffmann J; Knox JJ; Scholler J; Marcellus B; Allman D; Fraietta JA; Samelson-Jones B; Milone MC; Monos D; Garfall AL; Naji A; Bhoj VG
    Cell Rep Med; 2023 Dec; 4(12):101336. PubMed ID: 38118406
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. treatment of Internal Mammary Nodes is Associated With Improved Overall Survival in Breast cancer: A Meta-Analysis.
    Shaikh PM; Mulherkar R; Khasawneh MT; Clump D; Hazard-Jenkins H; Hafez M; Vargo JA
    Am J Clin Oncol; 2024 Feb; 47(2):81-87. PubMed ID: 37916961
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Swallowing disorders and mortality in adults with advanced cancer outside the head and neck and upper gastrointestinal tract: a systematic review.
    Silva DNM; Vicente LCC; Glória VLP; de Lima Friche AA
    BMC Palliat Care; 2023 Oct; 22(1):150. PubMed ID: 37798715
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. EV-301 long-term outcomes: 24-month findings from the phase III trial of enfortumab vedotin versus chemotherapy in patients with previously treated advanced urothelial carcinoma.
    Rosenberg JE; Powles T; Sonpavde GP; Loriot Y; Duran I; Lee JL; Matsubara N; Vulsteke C; Castellano D; Mamtani R; Wu C; Matsangou M; Campbell M; Petrylak DP
    Ann Oncol; 2023 Nov; 34(11):1047-1054. PubMed ID: 37678672
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Anti-bcma surface engineered biomimetic photothermal nanomissile enhances multiple myeloma cell apoptosis and overcomes the disturbance of NF-κB signaling in vivo.
    Xiao X; Ma Z; Li Z; Deng Y; Zhang Y; Xiang R; Zhu L; He Y; Li H; Jiang Y; Zhu Y; Xie Y; Peng H; Liu X; Wang H; Ye M; Zhao Y; Liu J
    Biomaterials; 2023 Jun; 297():122096. PubMed ID: 37075614
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Chronic Use of Hydrochlorothiazide and Risk of skin cancer in Caucasian Adults: A PharmLines Initiative Inception Cohort Study.
    Haisma MS; Greven N; Logendran M; Bos J; van der Vegt B; Horváth B; De Vos S; De Bock GH; Hak E; Rácz E
    Acta Derm Venereol; 2023 Apr; 103():adv3933. PubMed ID: 37014269
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Safety and efficacy of Pucotenlimab (HX008) - a humanized immunoglobulin G4 monoclonal antibody in patients with locally advanced or metastatic melanoma: a single-arm, multicenter, phase II study.
    Cui C; Chen Y; Luo Z; Zou Z; Jiang Y; Pan H; Fan Q; Zhao J; Xu Q; Jiang R; Wang X; Ma T; Guo Z; Si L; Chi Z; Sheng X; Dou Y; Tan Q; Wu D; Guo J
    BMC Cancer; 2023 Feb; 23(1):121. PubMed ID: 36747118
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. T-cell-engaging antibodies for the treatment of solid tumors: challenges and opportunities.
    Baeuerle PA; Wesche H
    Curr Opin Oncol; 2022 Sep; 34(5):552-558. PubMed ID: 35880455
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Cost-effectiveness of Artificial Intelligence as a Decision-Support System Applied to the Detection and Grading of Melanoma, Dental Caries, and Diabetic Retinopathy.
    Gomez Rossi J; Rojas-Perilla N; Krois J; Schwendicke F
    JAMA Netw Open; 2022 Mar; 5(3):e220269. PubMed ID: 35289862
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Inpatient care for skin diseases in Germany: multi-source analysis on the current and future health care needs.
    Augustin M; Girbig G; Kis A; Bechara FG; Hertl M; Hischke S; Kaufmann R; Löffler H; Müller CSL; Simon JC; Strömer K; Welzel J; Wetzig T; Elsner P; Augustin J; Löser C; Biedermann T
    J Dtsch Dermatol Ges; 2021 Oct; 19 Suppl 5():25-53. PubMed ID: 34662491
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. OTUB1 knockdown promotes apoptosis in melanoma cells by upregulating TRAIL expression.
    Lee BS; Kang SU; Huang M; Kim YS; Lee YS; Park JY; Kim CH
    BMB Rep; 2021 Dec; 54(12):608-613. PubMed ID: 34488924
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Pivotal factors associated with the immunosuppressive tumor microenvironment and melanoma metastasis.
    Zhang C; Dang D; Cong L; Sun H; Cong X
    Cancer Med; 2021 Jul; 10(14):4710-4720. PubMed ID: 34159752
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. MORTALITY OF PATIENTS WITH UVEAL MELANOMA DETECTED BY DIABETIC RETINOPATHY SCREENING.
    Hussain R; Czanner G; Taktak A; Damato B; Praidou A; Heimann H
    Retina; 2020 Nov; 40(11):2198-2206. PubMed ID: 32032260
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Methotrexate treatment for patients with psoriasis and risk of cutaneous melanoma: a nested case-control study.
    Polesie S; Gillstedt M; Paoli J; Osmancevic A
    Br J Dermatol; 2020 Oct; 183(4):684-691. PubMed ID: 31981364
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Single-Cell Lymphocyte Heterogeneity in Advanced Cutaneous T-cell Lymphoma skin Tumors.
    Gaydosik AM; Tabib T; Geskin LJ; Bayan CA; Conway JF; Lafyatis R; Fuschiotti P
    Clin Cancer Res; 2019 Jul; 25(14):4443-4454. PubMed ID: 31010835
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Physician-patient communication and patient-reported outcomes in the actinic keratosis treatment adherence initiative (AK-TRAIN): a multicenter, prospective, real-life study of treatment satisfaction, quality of life and adherence to topical field-directed therapy for the treatment of actinic keratosis in Italy.
    Neri L; Peris K; Longo C; Calvieri S; Frascione P; Parodi A; Eibenschuz L; Bottoni U; Pellacani G;
    J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):93-107. PubMed ID: 29920789
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. High expression of B lymphocyte stimulator in lesional keratinocytes of patients with cutaneous lupus erythematosus.
    Wenzel J; Landmann A; Vorwerk G; Kuhn A
    Exp Dermatol; 2018 Jan; 27(1):95-97. PubMed ID: 28833566
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Hepatic Progression-free and Overall Survival After Regional Therapy to the Liver for Metastatic Melanoma.
    Abbott AM; Doepker MP; Kim Y; Perez MC; Gandle C; Thomas KL; Choi J; Shridhar R; Zager JS
    Am J Clin Oncol; 2018 Aug; 41(8):747-753. PubMed ID: 28059929
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Significant symptoms alleviation and tumor volume reduction after combined simultaneously integrated inner-escalated boost and volumetric-modulated arc radiotherapy in a patient with unresectable bulky hepatocellular carcinoma: A care-compliant case report.
    Lin YH; Hung SK; Chiou WY; Lee MS; Shen BJ; Chen LC; Liu DW; Tsai WT; Lin PH; Shih YT; Hsu FC; Tsai SJ; Chan MWY; Lin HY
    Medicine (Baltimore); 2016 Aug; 95(34):e4717. PubMed ID: 27559982
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Partial breast irradiation for early breast cancer.
    Hickey BE; Lehman M; Francis DP; See AM
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD007077. PubMed ID: 27425375
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.